Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.

Prescott J, Safronetz D, Haddock E, Robertson S, Scott D, Feldmann H.

Immunology. 2013 Oct;140(2):168-78. doi: 10.1111/imm.12116.

2.

Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.

Schountz T, Quackenbush S, Rovnak J, Haddock E, Black WC 4th, Feldmann H, Prescott J.

J Virol. 2014 Aug;88(15):8319-31. doi: 10.1128/JVI.00004-14. Epub 2014 May 14.

3.

Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.

McElroy AK, Smith JM, Hooper JW, Schmaljohn CS.

Virology. 2004 Aug 15;326(1):130-9.

4.

Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, Larsen T, Hooper JW.

J Virol. 2007 Jul;81(14):7449-62. Epub 2007 May 2.

5.

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.

Hammerbeck CD, Brocato RL, Bell TM, Schellhase CW, Mraz SR, Queen LA, Hooper JW.

J Virol. 2016 Jun 24;90(14):6200-15. doi: 10.1128/JVI.00304-16. Print 2016 Jul 15.

6.

Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H.

J Virol. 2011 Dec;85(23):12781-91. doi: 10.1128/JVI.00794-11. Epub 2011 Sep 14.

7.

A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Brocato RL, Hammerbeck CD, Bell TM, Wells JB, Queen LA, Hooper JW.

J Virol. 2014 Jan;88(2):811-9. doi: 10.1128/JVI.02906-13. Epub 2013 Nov 6.

8.

Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.

Spengler JR, Haddock E, Gardner D, Hjelle B, Feldmann H, Prescott J.

PLoS One. 2013;8(1):e55310. doi: 10.1371/journal.pone.0055310. Epub 2013 Jan 31.

9.

A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters.

Vergote V, Laenen L, Vanmechelen B, Van Ranst M, Verbeken E, Hooper JW, Maes P.

PLoS Negl Trop Dis. 2017 Oct 27;11(10):e0006042. doi: 10.1371/journal.pntd.0006042. eCollection 2017 Oct.

10.

Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.

Martinez VP, Padula PJ.

J Med Virol. 2012 Jan;84(1):87-95. doi: 10.1002/jmv.22228.

PMID:
22095538
11.

Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.

Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC.

J Virol. 2009 Jul;83(14):7285-95. doi: 10.1128/JVI.00373-09. Epub 2009 Apr 29.

12.

Hantavirus pulmonary syndrome.

Macneil A, Nichol ST, Spiropoulou CF.

Virus Res. 2011 Dec;162(1-2):138-47. doi: 10.1016/j.virusres.2011.09.017. Epub 2011 Sep 17. Review.

PMID:
21945215
13.

The Syrian hamster model of hantavirus pulmonary syndrome.

Safronetz D, Ebihara H, Feldmann H, Hooper JW.

Antiviral Res. 2012 Sep;95(3):282-92. doi: 10.1016/j.antiviral.2012.06.002. Epub 2012 Jun 15. Review.

14.

A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).

Hooper JW, Josleyn M, Ballantyne J, Brocato R.

Vaccine. 2013 Sep 13;31(40):4314-21. doi: 10.1016/j.vaccine.2013.07.025. Epub 2013 Jul 24.

15.

T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.

Hammerbeck CD, Hooper JW.

J Virol. 2011 Oct;85(19):9929-44. doi: 10.1128/JVI.05356-11. Epub 2011 Jul 20. Erratum in: J Virol. 2012 Apr;86(7):4043.

16.

Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.

Matthys VS, Gorbunova EE, Gavrilovskaya IN, Mackow ER.

J Virol. 2010 Jan;84(1):352-60. doi: 10.1128/JVI.01013-09.

17.

Development of reassortant viruses between pathogenic hantavirus strains.

Rizvanov AA, Khaiboullina SF, St Jeor S.

Virology. 2004 Oct 1;327(2):225-32.

18.

Maporal Hantavirus Causes Mild Pathology in Deer Mice (Peromyscus maniculatus).

McGuire A, Miedema K, Fauver JR, Rico A, Aboellail T, Quackenbush SL, Hawkinson A, Schountz T.

Viruses. 2016 Oct 18;8(10). pii: E286.

19.

In vitro and in vivo activity of ribavirin against Andes virus infection.

Safronetz D, Haddock E, Feldmann F, Ebihara H, Feldmann H.

PLoS One. 2011;6(8):e23560. doi: 10.1371/journal.pone.0023560. Epub 2011 Aug 10.

20.

Transcriptome markers of viral persistence in naturally-infected andes virus (bunyaviridae) seropositive long-tailed pygmy rice rats.

Campbell CL, Torres-Perez F, Acuna-Retamar M, Schountz T.

PLoS One. 2015 Apr 9;10(4):e0122935. doi: 10.1371/journal.pone.0122935. eCollection 2015.

Supplemental Content

Support Center